[Taipei, Taiwan] – [June 13, 2025]
YC Biotech today announced the official launch and ongoing progress of its Alzheimer’s disease stem cell clinical trial, conducted in collaboration with its trusted partner, JY BioMed. This partnership aims to explore the potential of stem cell therapy in slowing the progression of Alzheimer’s disease and improving cognitive function, offering renewed hope to millions of people worldwide affected by this debilitating condition.
Alzheimer’s disease, a complex and devastating neurodegenerative disorder, currently has no effective cure. With the global population aging, its prevalence is steadily rising, posing a serious public health challenge. YC Biotech has consistently supported the development of innovative medical technologies. Stem cells, as a key element in regenerative medicine, show great promise in repairing damaged neurons and inhibiting neuroinflammatory responses, thereby opening new avenues for the treatment of Alzheimer’s disease.
Mr. Lin Yu-Ming, CEO of YC Biotech, stated, “We are honored to collaborate with JY BioMed in advancing this deeply significant clinical trial. Alzheimer’s disease causes immense suffering not only for patients but also for their families. We firmly believe that, through the combined top-tier scientific expertise and clinical experience of both parties, we can bring more hopeful treatment options to patients. This trial will strictly adhere to international clinical trial regulations, ensuring scientific rigor, integrity, and patient safety.”
The initiation of this clinical trial marks another significant milestone in the application of stem cell therapy for the treatment of neurodegenerative diseases. The trial’s results are expected to provide valuable insights into the pathological mechanisms of Alzheimer’s disease and lay a solid foundation for the future clinical application of stem cell therapy. YC Biotech, JY BioMed, and Taipei Medical University Hospital will continue their close cooperation to accelerate the translation of research findings into effective therapies for patients worldwide.
